Preferred Label : TOR Serine-Threonine kinases;
MeSH definition : A serine threonine kinase that controls a wide range of growth-related cellular processes.
The protein is referred to as the target of RAPAMYCIN due to the discovery that SIROLIMUS
(commonly known as rapamycin) forms an inhibitory complex with TACROLIMUS BINDING
PROTEIN 1A that blocks the action of its enzymatic activity.;
MeSH synonym : kinases, TOR Serine-Threonine; Serine-Threonine kinases, TOR; FKBP12-Rapamycin associated protein; FKBP12 rapamycin associated protein; FKBP12-Rapamycin Complex-Associated protein; FKBP12 rapamycin complex associated protein; mechanistic target of rapamycin protein; TOR kinases; mTOR Serine-Threonine kinases; kinases, mTOR Serine-Threonine; Serine-Threonine kinases, mTOR; mTOR serine threonine kinases; RAFT-1 protein; protein, RAFT-1; RAFT 1 protein; rapamycin target protein; target of rapamycin proteins; FK506 binding protein 12-Rapamycin associated protein 1; FK506 binding protein 12 rapamycin associated protein 1; mTOR protein; protein, mTOR; TOR serine threonine kinases; Mammalian Target of Rapamycin; Target of Rapamycin Protein; Protein Target, Rapamycin; Rapamycin Protein Target; mTOR Serine-Threonine Kinase; Kinase, mTOR Serine-Threonine; Serine-Threonine Kinase, mTOR; mTOR Serine Threonine Kinase; TOR Kinase; Kinase, TOR; TOR Serine-Threonine Kinase; Kinase, TOR Serine-Threonine; Serine-Threonine Kinase, TOR; TOR Serine Threonine Kinase;
CISMeF synonym : Complex-Associated protein, FKBP12-Rapamycin; associated protein, FKBP12-Rapamycin; protein, FKBP12-Rapamycin Complex-Associated; protein, FKBP12-Rapamycin associated; protein, rapamycin target; rapamycin proteins target; target protein, rapamycin;
Registry Number MeSH : EC 2.7.1.1;
Is substance : O;
UNII : EC 2.7.11.1;
Origin ID : D058570;
UMLS CUI : C0293060;
Allowable qualifiers
Indexing information
Record concept(s)
Related MeSH Supplementary Concept(s)
See also
See also (suggested by CISMeF)
Semantic type(s)
A serine threonine kinase that controls a wide range of growth-related cellular processes.
The protein is referred to as the target of RAPAMYCIN due to the discovery that SIROLIMUS
(commonly known as rapamycin) forms an inhibitory complex with TACROLIMUS BINDING
PROTEIN 1A that blocks the action of its enzymatic activity.
http://www.sfendocrino.org/_images/mediatheque/articles/pdf/recommandations/2018_Immunotherapies%20/mced_94_bd.pdf
2018
false
false
false
France
French
immunotherapy
antibodies, monoclonal
consensus
continuity of patient care
Tyrosine Kinase Inhibitor
protein-tyrosine kinases
protein kinase inhibitors
TOR Serine-Threonine kinases
adrenal glands
pituitary gland
metabolism
endocrine system diseases
diabetes mellitus
Hypophysitis
hypothyroidism
adrenal insufficiency
Hormone Measurement
hormones
Tyrosine Kinase Inhibitors
---